An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms
- PMID: 2875664
- DOI: 10.1176/ajp.143.9.1162
An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms
Abstract
Factors associated with the emergence or nonemergence of involuntary movements (tardive dyskinesia) during long-term neuroleptic treatment were investigated in an atypical, isolated population of 31 schizophrenic inpatients with an unusually high prevalence of this syndrome. Patients with involuntary movements could not be distinguished from those without such movements by general characteristics or conventional indices of neuroleptic or anticholinergic treatment. However, they were more likely to show either marked cognitive dysfunction or muteness. These findings support the proposal that, at least in schizophrenia, subtle organic changes may contribute to vulnerability to the emergence of involuntary movements.
Similar articles
-
Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality.Arch Gen Psychiatry. 1987 Oct;44(10):907-12. doi: 10.1001/archpsyc.1987.01800220077011. Arch Gen Psychiatry. 1987. PMID: 2889438
-
Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies.J Clin Psychiatry. 1985 Apr;46(4 Pt 2):29-33. J Clin Psychiatry. 1985. PMID: 2858476
-
Cognitive dysfunction in schizophrenia: organic vulnerability factor or state marker for tardive dyskinesia?Brain Cogn. 1993 Sep;23(1):56-70. doi: 10.1006/brcg.1993.1044. Brain Cogn. 1993. PMID: 8105822
-
[Schizophrenic deficit syndrome and neurologic tolerance].Encephale. 1996 Jun;22 Spec No 2:45-7. Encephale. 1996. PMID: 8767042 Review. French.
-
Prevalence of spontaneous dyskinesia in schizophrenia.J Clin Psychiatry. 2000;61 Suppl 4:10-4. J Clin Psychiatry. 2000. PMID: 10739325 Review.
Cited by
-
Drug-induced movement disorders.Drug Saf. 1997 Mar;16(3):180-204. doi: 10.2165/00002018-199716030-00004. Drug Saf. 1997. PMID: 9098656 Review.
-
Parkinsonism, Psychomotor Slowing, Negative and Depressive Symptoms in Schizophrenia Spectrum and Mood Disorders: Exploring Their Intricate Nexus Using a Network Analytic Approach.Schizophr Bull. 2025 Mar 14;51(2):556-570. doi: 10.1093/schbul/sbae055. Schizophr Bull. 2025. PMID: 38665097 Free PMC article.
-
The ageing brain, neuroleptic drugs and the enigma of schizophrenia.Ir J Med Sci. 1988 May;157(5):135-41. doi: 10.1007/BF02949282. Ir J Med Sci. 1988. PMID: 2906348 Review. No abstract available.
-
Negative symptoms, defect state and Huber's basic symptoms: a comparison of the concepts.Psychiatr Q. 1991 Winter;62(4):277-98. doi: 10.1007/BF01958797. Psychiatr Q. 1991. PMID: 1809980 Review.
-
Tardive dystonia. Prevalence, risk factors, and comparison with tardive dyskinesia in a population of 200 acute psychiatric inpatients.Eur Arch Psychiatry Clin Neurosci. 1995;245(3):145-51. doi: 10.1007/BF02193087. Eur Arch Psychiatry Clin Neurosci. 1995. PMID: 7669821
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical